A new gold(III)-aminoethyl imidazolium aurate salt: Synthesis, characterization and reactivity

Tetrachloroauric acid HAuCl₄ reacts with the ionic liquid 1-(2-aminoethyl)-3-methylimidazolium nitrate [NH₂(CH₂)₂ImMe]NO₃, (2b) or its dicationic ammonium salt [NH₃(CH₂)₂ImMe][NO₃]₂, (3) in methanolic solutions to give the novel gold(III)-aminoethyl imidazolium aurate salt [Cl₃AuNH₂(CH₂)₂ImMe][AuCl₄] (4). The reaction of 4 with [ⁿBu₄]Cl gives [NH₂(CH₂)₂ImMe][AuCl₄] (2c) whereas with acetone the dicationic, iminium-functionalized, imidazolium aurate salt [Me₂C=N(H)(CH₂)₂ImMe][AuCl₄]₂ (5) has been isolated. The structures in the solid state of 2c, 3, 4, and 5 have been determined by X-ray diffraction. The electrochemical behaviour of 4 has been examined by Cyclic voltammetry in acetonitrile and compared with 2c and KAuCl₄.     

Synthesis and characterisation of a series of 1,2-phenylenedioxoborylcyclopentadienyl-metal complexes [Ti(IV), Zr(IV), Hf(IV), La(III), Ce(III), Yb(III), Sn(II) and Fe(II)]

The preparation of a series of 1,2-phenylenedioxoborylcyclopentadienyl-metal complexes is described. These are of formula [M{η⁵-C₅H₄(BX)}Cl₃] [M = Ti and X = CAT (2a), CAT^t (2b) or CAT^tt (2c); X = CAT^tt and M = Zr (4a) or Hf (4b)], [M{η⁵-C₅H₄(BX)}₂Cl₂] [M = Zr, X = CAT (3a) or CAT^t (3c); or M = Hf, X = CAT (3b) or CAT^t (3d)], [M{(μ-η⁵-C₅H₃BCAT)₂ SiMe₂}Cl₂] [M = Zr (5a) or Hf (5b)], [M{η⁵-C₅H₃(BCAT)₂}Cl₃] [M = Zr (6a) or Hf (6b)], [M{η⁵-C₅H₄BCAT}₃(THF)] [M = La (7a), Ce (7b) or Yb (7c)], [Sn{η⁵-C₅ H₄(BCAT^t)}Cl](8) and [Fe{η⁵-C₅H₄(BCAT^t)}₂] (9). The abbreviations refer to BO₂C₆H₄-1,2 (BCAT) and the 4-Bu^t (BCAT^t) and the (BCAT^tt) analogues. The compounds 2a-9 have been characterised by microanalysis, multinuclear NMR and mass spectra. The single crystal X-ray structure of the lanthanum compound 7a is presented.     

(Pyrazolylmethyl)pyridine platinum(II) and gold(III) complexes: Synthesis, structures and evaluation as anticancer agents

Reactions of 2-(3,5-dimethylpyrazol-1-ylmethyl)pyridine (L1), 2-(3,5-diphenylpyrazol-1-ylmethyl)pyridine (L2), 2-(3,5-di-tert-butylpyrazol-1-ylmethyl)pyridine (L3) and 2-(3-p-tolylpyrazol-1-ylmethyl)pyridine (L4) with K₂[PtCl₄] in a mixture of ethanol and water formed the dichloro platinum complexes [PtCl₂(L1)] (1), [PtCl₂(L2)] (2), [PtCl₂(L3)] (3) and [PtCl₂(L4)] (4). Complex 1, [PtCl₂(L1)], could also be prepared in a mixture of acetone and water. Performing the reactions of L2 and L3 in a mixture of acetone and water, however, led to C-H activation of acetone under mild conditions to form the neutral acetonyl complexes [Pt(CH₂COCH₃)Cl(L2)] (2a) and [Pt(CH₂COCH₃)Cl(L3)] (3a). The same ligands reacted with HAuCl₄ · 4H₂O in a mixture of ethanol and water to form the gold salts [AuCl₂(L1)][AuCl₄] (5) [AuCl₂(L2)][Cl] (6) [AuCl₂(L3)][Cl] (7) and [AuCl₂(L4)][AuCl₄] (8); however, with the pyrazolyl unit in the para position of the pyridinyl ring in 4-(3,5-dimethylpyrazol-1-ylmethyl)pyridine (L5), 4-(3,5-diphenylpyrazol-1-ylmethyl)pyridine (L6) neutral gold complexes [AuCl₃(L5)] (9) and [AuCl₂(L6)] (10) were formed; signifying the role the position of the pyrazolyl group plays in product formation in the gold reactions. X-ray crystallographic structural determination of L6, 2, 33a, 8 and 10 were very important in confirming the structures of these compounds; particularly for 3a and 8 where the presence of the acetonyl group confirmed C-H activation and for 8 where the counter ion is . Cytotoxicity studies of L2, L4 and complexes 1-10 against HeLa cells showed the Au complexes were much less active than the Pt complexes.     

Bis(pyrazolyl) palladium(II), platinum(II) and gold(III) complexes: Syntheses, molecular structures and substitution reactions with l-cysteine

A series of pyrazolyl palladium(II), platinum(II) and gold(III) complexes, [PdCl₂(3,5-R₂bpza)] {R = H (1), R = Me (2), bpza = bis-pyrazolyl acetic acid}, [PtCl₂(3,5-R₂bpza)] {R = H (3a), R = Me (4)}, [AuCl₂(3,5-R₂bpza)]Cl {R = H (5a), R = Me (6a)} and [PdCl₂(3,5-R₂bpzate)] {R = Me (7)} have been synthesised and structurally characterised. Single crystal X-ray crystallography showed that the pyrazolyl ligands exhibit N^N-coordination with the metals. Anticancer activities of six complexes 1-6a were investigated against CHO cells and were found to have low activities. Substitution reactions of selected complexes 1, 2, 3a and 5a with l-cysteine show that the low anticancer activities compounds and that the rate of substitution with sulfur-containing compounds is not the cause of the low anticancer activities.     

A report describing the effect of di-2-pyridyl ligand architecture on the coordination properties with gold(III)

In an effort to develop novel gold-based chemotherapies, gold(III) coordination complexes possessing a series of di-2-pyridyl ligands were targeted as synthetic products. It was found that di-2-pyridyl ligands linked by different groups exhibited varying coordination to gold(III). Di-2-pyridyl sulfide (DPS) exhibited bidentate binding to gold(III), and formed a complex ion with a gold tetrachloride counter ion {[(DPS)AuCl₂]AuCl₄; compound 3}; di-2-pyridyl ether (DPO) formed a neutral monodentate coordination complex with gold(III) {[(DPO)(AuCl₃)]; compound 4}; and attempts to make a gold(III) complex with di-2-pyridyl ketone (DPK) were unsuccessful, as a complex ion possessing the protonated ligand and a gold tetrachloride anion was isolated {[HDPK][AuCl₄]; compound 5}. Compounds 3-5 were structurally characterized using X-ray crystallography, which confirmed the different coordination environments around the gold(III) metal centers.     

Cyclometalated rhodium(III) and iridium(III) complexes containing amino acids as N,O-chelates

The synthesis of bis-cyclometalated aminocarboxylato complexes [M(α-aminocarboxylato)(ptpy)₂] (M = Rh, 3, 4, 5; M = Ir, 6, 7, 8), ptpy = 2-(p-tolyl)pyridinato; aminocarboxylato = glycinato, l-alaninato, l-prolinato) from [{M(μ-Cl)(ptpy)₂}₂] (M = Rh, 1; M = Ir, 2) is described. The molecular structure of [Ir(l-alaninato)(ptpy)₂] (7) was confirmed by a single-crystal X-ray diffraction study. Compound 7 crystallized from methanol-iso-hexane in the space group P2₁. For 7 the two diastereoisomers Δ_Ir, S_C and Λ_Ir, S_C were found crystallizing twice per unit. Absorption and emission spectra were recorded. The rhodium compounds are weak yellow-green and the iridium species strong green emitters.     

Ruthenium(VI) and osmium(VI) nitrido complexes with halogenated phenoxide and thiophenoxide ligands

Treatment of [Buⁿ₄N][Ru(N)Cl₄] with Na(OR) afforded [Buⁿ₄N][Ru(N)(OR)₄] (R = C₆F₅ (1), C₆F₄H (2), C₆Br₅ (3)), whereas that with [Buⁿ₄N][Os(N)Cl₄] gave [Buⁿ₄N][Os(N)(OR)₃Cl] (R = C₆F₅ (4), C₆F₄H (5), C₆Br₅ (6)). Treatment of [Buⁿ₄N][M(N)Cl₄] with Na(SC₆F₄H) and Na(Sxyl) (xyl = 2,6-dimethylphenyl) afforded [Buⁿ₄N][M(N)(SC₆F₄H)₄] (M = Ru (7), Os (8)) and [Buⁿ₄N][M(N)(Sxyl)₄] (M = Ru (9), Os (10)), respectively. The crystal structures of compounds 1, 6 and 9 have been determined.     

Rhenium(III) and technetium(III) complexes with 2-mercapto-1,3-azole ligands and X-ray crystal structures

Reactions of labile [MCl₃(PPh₃)₂(NCMe)] (M = Tc, Re) precursors with 1H-benzoimidazole-2-thiol (H₂L¹), 5-methyl-1H-benzoimidazole-2-thiol (H₂L²) and 1H-imidazole-2-thiol (H₂L³), in the presence of PPh₃ and [AsPh₄]Cl gave a new series of trigonal bipyramidal M(III) complexes [AsPh₄]{[M(PPh₃)Cl(H₂L^1-3)₃]Cl₃} (M = Re, 1-3; M = Tc, 4-6). The molecular structures of 1 and 3 were determined by X-ray diffraction. When the reactions were carried out with benzothiazole-2-thiol (HL⁴) and benzoxazole-2-thiol (HL⁵), neutral paramagnetic monosubstituted M(III) complexes [M(PPh₃)₂Cl₂(L^4,5)] (M = Re, 8, 9; M = Tc, 10, 11) were obtained. In these compounds, the central metal ions adopt an octahedral coordination geometry as authenticated by single crystal X-ray diffraction analysis of 8 and 11. Rhenium and technetium complexes 1, 4 and rhenium chelate compounds 8, 9 have been also synthesized by reduction of [MO₄]⁻ with PPh₃ and HCl in the presence of the appropriate ligand. All the complexes were characterized by elemental analyses, FTIR and NMR spectroscopy.     

Syntheses and structures of heterobimetallic complexes derived from [Ga(edt)2] as a metalloligand (edt = SC2H4S): Potential precursors for ternary materials MGaS2 (M = Cu or Ag)

Metathesis reaction between equimolar amount of [Et₄N][GaCl₄] and Na₂edt in methanol resulted in the formation of the dichloro complex [Et₄N][Ga(edt)Cl₂] (1), whereas reaction of [Et₄N][GaCl₄] with two equivalents of Na₂edt in methanol gave the complex [Et₄N][Ga(edt)₂] (2) which can act as a metalloligand. Treatment of 2 with M(PPh₃)₂NO₃ in DMF/CH₂Cl₂ afforded the heterobimetallic complexes [Ga(edt)₂M-(PPh₃)₂] (M = Cu 3, Ag 4) in moderate yields. The structures of 1-4 were determined by single-crystal X-ray diffraction analyses. Both [Ga(edt)Cl₂]⁻ and [Ga(edt)₂]⁻ anions have a distorted tetrahedral geometry. The former consists of one five-membered ring formed by chelating dithiolate and two terminal chloride atoms while the latter consists of two five-membered rings formed by two the chelating dithiolates. Complexes 3 and 4 consist of metalloligand [Ga(edt)₂]⁻ anion chelated to [M(PPh₃)₂]⁺via the sulfur atoms. Both tetrahedrally coordinated Ga and Cu(Ag) atoms are bridged by two sulfur atoms, forming a planar “GaS₂M” (M = Cu, Ag) core. Thermogravimetry analysis revealed that heterobimetallic complexes 3 and 4 decomposed to give the corresponding ternary metal sulfide materials.     

DNA interaction and cytotoxicity studies of new ruthenium(II) cyclopentadienyl derivative complexes containing heteroaromatic ligands

Four ruthenium(II) complexes with the formula [Ru(η⁵-C₅H₅)(PP)L][CF₃SO₃], being (PP = two triphenylphosphine molecules), L = 1-benzylimidazole, ; (PP = two triphenylphosphine molecules), L = 2,2′bipyridine, ; (PP = two triphenylphosphine molecules), L = 4-Methylpyridine, ; (PP = 1,2-bis(diphenylphosphine)ethane), L = 4-Methylpyridine, , were prepared, in view to evaluate their potentialities as antitumor agents. The compounds were completely characterized by NMR spectroscopy and their crystal and molecular structures were determined by X-ray diffraction. Electrochemical studies were carried out giving for all the compounds quasi-reversible processes. The images obtained by atomic force microscopy (AFM) suggest interaction with pBR322 plasmid DNA. Measurements of the viscosity of solutions of free DNA and DNA incubated with different concentrations of the compounds confirmed this interaction. The cytotoxicity of compounds 1234 was much higher than that of cisplatin against human leukemia cancer cells (HL-60 cells). IC₅₀ values for all the compounds are in the range of submicromolar amounts. Apoptotic death percentage was also studied resulting similar than that of cisplatin.     

A preparative study of some coronands and their complexation of silver(I), zinc(II), cadmium(II) and lead(II)

A study of the complexation of heavy metal ions by the coronands 3,12,20,29-tetraoxa-35,36-diazapentacyclo[29.3.1.1.^14,18.0^5,10.0^22,27]-hexatriaconta-1(35),5(10),6,8,14,16,18(36),22(27),23,25,31,33-dodecaene (1); 2,3,11,12-bis (4^′-methylbenzo)-1,4,10,13-tetrathia-7,16-dioxacyclo-octadeca-2,11-diene (2); 7,16-diaza-1,4,10,13-tetraoxa-2,3,11,12-dibenzocyclooctadeca-2,11-diene (3); 2-[19-(2-hydroxy-2-phenylethyl)-7,8,9,10, 18,19,20,21-octahydro-6H,17H-dibenzo[b,k][1,4,10,13,7,16]tetraoxadiazacyclooctadecin-8-yl]-1-phenyl-1-ethanol (4); 1,4,10,13-tetraoxa-7,16-diazacyclo-octadecane (5); and 2-[16-(2-hydroxy-2-phenylethyl)-1,4,10,13-tetraoxa-7,16-diazacyclo-octadecanyl]-1-phenyl-1-ethanol (6) is described. Coronands 1 and 3 were prepared by literature methods, improved methods were used to prepare 2, and 4 and 6 were prepared from 3 and 5 (obtained commercially), respectively. Potentiometric studies in N,N-dimethylformamide yielded (logK/dm³ mol⁻¹)=5.50, 6.49, 9.42 and 7.52 for [Ag · 1]⁺, [Ag · 2]⁺, [Ag · 5]⁺ and [Ag · 6]⁺, respectively; <2, <2, 4.30 and <2 for [Zn · 1]²⁺, [Zn · 2]²⁺, [Zn · 5]²⁺ and [Zn · 6]²⁺, respectively, <2, <2, 5.92 and >7.52 for [Cd · 1]²⁺, [Cd · 2]²⁺, [Cd · 5]²⁺, and [Cd · 6]²⁺, respectively, and 2.62, 2.38, 6.71 and >7.52 for [Pb · 1]²⁺, [Pb · 2]²⁺, [Pb · 5]²⁺, and [Pb · 6]²⁺, respectively. ESI-MS studies of the interactions of 1-6 with Ag⁺, Zn²⁺, Cd²⁺ and Pb²⁺ are also reported.     

Reduction of diruthenium(II,III) carboxylate compounds with hydroquinone: a facile preparation of diruthenium(II) complexes

The synthesis of the diruthenium(II) compounds [Ru₂(μ-O₂CR)₄(MeOH)₂] [R = Me (1), Ph (2), CMePh₂ (3) C₆H₄-p-OMe (4), C₆H₄-p-CMe₃ (5)] by reaction of with hydroquinone, under a nitrogen atmosphere, in the presence of a base is described. This reaction constitutes an easy via to the preparation of diruthenium(II) compounds. The structure of the complexes [Ru₂(μ-O₂CMe)₄(MeOH)₂] (1) and [Ru₂(μ-O₂CPh)₄(thf)₂] (2b) is established by single crystal X-ray diffraction. These compounds show a diruthenium(II) unit bridged by four carboxylate ligands with the axial positions occupied by methanol and tetrahydrofuran molecules for 1 and 2b, respectively. Complex 1 shows, in the solid state, polymeric chains in which the molecules [Ru₂(μ-O₂CMe)₄(MeOH)₂] are linked by hydrogen bonds.     

Differential effects of Co(III), Ni(II), and Ru(III) amine complexes on Sindbis virus

Transition metal complexes [Co(cyclen)(NH₃)₂](ClO₄)₃⋅H₂O (cyclen = 1,4,7,10-tetraazacyclododecane) (2), [Co(NH₃)₅(OH₂)](CF₃SO₃)₃ (3) [Ni(NH₃)₆]Br₂ (4) and [Ru(NH₃)₆]Cl₃ (5) were tested against Sindbis infected baby hamster kidney (BHK) cells and show differential effects from the previously reported anti-viral complex [Co(NH₃)₆]Cl₃ (1). The macrocyclic complex 2 and labile aqua complex 3 show either no or little effect on the survival on Sindbis virus-infected cells as compared to that for 1, which show a monotonic increase in % BHK cell survival. Nickel and ruthenium ammine complexes 4 and 5 had a moderate influence of cell survival. While the results showed some anti-viral activity for some of the structural variations, it appears that 1, with its potential to be a broad-spectrum anti-viral compound, occupies a unique position in its ability to both significantly enhance cell survival and to decrease viral expression of infected cells. We also show that 1 also shows anti-viral activity against Adenovirus lending support to the broad-spectrum potential of this complex.     

Structural and magnetic properties of Ln(III) complexes with diimines and crotonato as a bridging ligand

Five new lanthanide complexes displaying crotonato bridges have been prepared: [Gd₂(crot)₆(H₂O)₄] · 4(bpa) (1); [Ho₂(crot)₇]_n · (Hbpa) (2); [Gd₂(crot)₆(bipy)₂] (3); [Ho₂(crot)₆(bipy)₂] (4) and [Nd₂(crot)₆(H₂O)₃]_n (5), where bipy=2,2^′-bipyridine; bpa=di(2-pyridyl)amine; crot=crotonato. The compounds were characterized by magnetic susceptibility measurements and their crystal structures were determined by single crystal X-ray diffraction. These studies showed complexes 1, 3 and 4 to be dimers while structures 2 and 5 are polymeric in nature.     

Transition metal halide salts of N-methylmorpholine: Synthesis, crystal structures and magnetic properties of N-methylmorpholinium salts of copper(II), cobalt(II) and manganese(II)

A family of complexes of N-methylmorpholinium metal halides has been synthesized and analyzed using X-ray crystallography and temperature dependant magnetic susceptibility. The compounds produced include (nmmH)₂[CuCl₄] (1), (nmmH)₂[CoCl₄] (2), (nmmH)₂[MnCl₄] (3), (nmmH)₂[CuBr₄] (4), (nmmH)₂[CoBr₄] (5), and (nmmH)₂[MnBr₄] (6) [nmmH = N-methylmorpholinium]. The compounds are all isomorphous and exhibit weak one dimensional antiferromagnetic interactions, with a contribution from single-ion anisotropy in the case of the cobalt complexes.     

Synthesis and structures of lithium salts of two cluster iodoarsenate(III)s and a periodohexaantimonate(III)

Treatment of the lithium β-diketiminate Li[{N(C₆H₃-2,6)C(Me)}₂CH] with an equivalent portion of arsenic(III) iodide unexpectedly afforded [Li(thf)₄]₂[As₈I₂₆] (1) in modest yield. Another new cluster anion featured in [Li(thf)₄]₂[Li(thf)₆][As₇I₂₄]·1.5(thf) (2) was obtained in excellent yield from lithium iodide and four equivalents of AsI₃ in thf. Using the same stoichiometry and solvent, but with SbI₃ in place of AsI₃, furnished in good yield [Li(thf)₄]₄[Sb₆I₂₂]·2(thf) (3). The structures of the new crystalline orange (1, 3) or orange/red (2) salts was established by single crystal X-ray diffraction. Each anion of 1-3 may be factorised into respectively [(AsI₂)₆(AsI)₂(μ₂-I)₁₀(μ₅-I)₂]²⁻ (1), [{(AsI₂)(μ₂-I)(μ₃-I)}₆As]³⁻ (2) and [(SbI₃)₂(SbI₂)₂(SbI)₂(μ₂-I)₆(μ₃-I)₄]⁴⁻ (3). Each As atom in 2 and each Sb atom in 3 is the centre of a six-coordinate distorted octahedron, while the arsenic atoms in 1 have either four- or six-coordinate environments.     

Synthesis and structural analysis of calix[4]arene-supported iron(III) complexes

The paper describes the reactivity of calix[4]arene dialkyl- or -silylethers H₂R₂calix, R=Me (1), Bz (2), or SiMe₃ (3) (p-tert.butyl-calix[4]arene=H₄calix), towards the iron(III) complex [FeCl(NSiMe₃)₂(thf)] 4. Bis(silylation) of H₄calix was achieved using a mixture of NEt₃ and Me₃SiCl as silylating agent, which is probably the most convenient and cheapest way for the preparation of H₂(Me₃Si)₂calix 3. [FeCl(N{SiMe₃}₂)₂(thf)] 4 has been obtained from the reaction of [FeCl₃] and commercially available K[N(SiMe₃)₂] in THF. The reactions of 4 with H₂Me₂calix and H₂Bz₂calix afford mononuclear iron(III) chloro compounds [FeCl(R₂calix)] 5 (R=Me) and 6 (R=Bz). The usage of calix[4]arene silyl ether 3 leads to a dinuclear complex [Fe₂({Me₃Si}calix)₂] 7, presumably under Me₃SiCl cleavage of a mononuclear calixarene iron(III) chloro complex. The calix[4]arene ether stabilized iron(III) chloro complexes are susceptible to nucleophilic substitution reactions, as exemplified by the reaction of 5 with sodium azide yielding an azido complex [Fe(N₃)(Me₂calix)] 8. The molecular structures of 4, 5, 6, 7, and 8 in the solid state have been determined by X-ray diffraction.     

Iron(III), chromium(III) and cobalt(II) complexes with squarate: Synthesis, crystal structure and magnetic properties

The preparation and variable temperature-magnetic investigation of three squarate-containing complexes of formula [Fe₂(OH)₂(C₄O₄)₂(H₂O)₄]·2H₂O (1) [Cr₂(OH)₂(C₄O₄)₂(H₂O)₄]·2H₂O (2) and [Co(C₄O₄)(H₂O)₄]_n (3) [H₂C₄O₄ = 3.4-dihydroxycyclobutene-1,2-dione (squaric acid)] together with the crystal structures of 1 and 3 are reported. Complex 1 contains discrete centrosymmetric [Fe₂(OH)₂(C₄O₄)₂(H₂O)₄] diiron(II) units where the iron pairs are joined by a di-μ-hydroxo bridge and two squarate ligands acting as bridging groups through adjacent oxygen atoms. Two coordinated water molecules in cis position complete the octahedral environment at each iron atom in 1. The iron-iron distance with the dinuclear unit is 3.0722(6) Å and the angle at the hydroxo bridge is 99.99(7)°, values which compare well with the corresponding ones in the isostructural compound 2 (2.998 Å and 99.47°) whose structure was reported previously. The crystal structure of 3 contains neutral chains of squarato-O¹,O³-bridged cobalt(II) ions where four coordinated water molecules complete the six-coordination at each cobalt atom. The cobalt-cobalt separation across the squarate bridge is 8.0595(4) Å. A relatively important intramolecular antiferromagnetic coupling occurs in 1 whereas it is very weak in 2, the exchange pathway being the same [J = −14.4 (1) and −0.07 cm⁻¹ (2), the spin Hamiltonian being defined as ]. A weak intrachain antiferromagnetic interaction between the high-spin cobalt(II) ions occurs in 3 (J = −0.30 cm⁻¹). The magnitude and nature of these magnetic interactions are discussed in the light of their respective structures and they are compared with those reported for related systems.     

Synthesis, crystal structure and characterizations of iron(III) and copper(II) complexes with the hydrazone ligand obtained from 2-formyl-pyridine and Girard’s T reagent

The condensation of 2-formyl-pyridine with Girard’s T reagent yields a new hydrazone in the form of an ammonium quaternary salt: [H(2-PyGT)]Cl. This tridentate ligand is readily soluble in water and reacts with iron(III) or copper(II) chlorides to give [Fe(2-PyGT)Cl₃] (1) or [Cu(2-PyGT)Cl₂]·(H₂O) (2) complexes, respectively. Single-crystal X-ray studies in 1 and 2 reveal that the coordination reaction gives rise to the deprotonation of the organic ligand that is coordinated using its NNO donor atoms in the form of a zwitterion species. The coordination spheres around the transition metal ions in complexes 1 and 2 are quite different. In 1, the iron site adopts a distorted octahedral coordination sphere, while the Cu(II) ions in 2 show a distorted tetragonal-pyramid geometry. As expected, the magnetic properties of these compounds reveal only weak antiferromagnetic interaction between spin carriers.